MICROPORT (00853) issues a profit warning, expecting to incur a net loss for the interim period.
Minimally Invasive Medical (00853) announced that the performance results for the six months ending June 30, 2026, are expected as follows: the Group's continuing operations revenue is anticipated to achieve a year-on-year growth of approximately 12% to 14%, with the overseas business continuing to contribute around 140% strong growth; the profitability of the Group's operations is steadily improving, with the gross margin of continuing operations increasing by about 3 to 4 percentage points year-on-year, while continuously promoting refined operations and cost control.
MICROPORT (00853) announced that the Groups performance for the six months ending June 30, 2026, is expected as follows: The Group's revenue from continuing operations is anticipated to grow by approximately 12% to 14% year-on-year, with particularly strong contributions from overseas operations, which continue to experience about 140% growth; the profitability of the Group at the operational level is steadily improving, with the gross margin of continuing operations expected to increase by approximately 3 to 4 percentage points year-on-year, while continuing to advance refined operations and cost control. During this period, the continuing operations are expected to achieve an operational net profit of no less than $24 million (for the six months ending June 30, 2025, the continuing operations recorded an operational net loss of $413 million); however, due to financial costs of approximately $43 million incurred during the period, as well as foreign exchange fluctuations, fair value reassessment of convertible loans, and one-time losses arising from several asset impairments and transaction matters, the Group anticipates a net loss from continuing operations during the period not exceeding $50 million (for the six months ending June 30, 2025, the continuing operations experienced a net loss of $49 million).
As of the date of this announcement, the Company has obtained a waiver related to the financial covenants applicable during the period under the relevant agreements for the convertible loans concerning the expected net loss. In the future, the Group will continue to uphold the "Focus on Core" strategy and seek mutually beneficial strategic solutions for its non-core/loss-making businesses, while appropriately arranging and continuously optimizing the Group's debt conditions and structure to further improve the Group's operational status and financial performance.
Related Articles

A-shares Evening Highlights | Central Bank Makes Major Announcement! Related to Monetary Policy, Exchange Rates, etc.

TIAN CHANG GP (02182) has signed a construction agreement with Guangdong Zhongfu for the establishment of a new production facility for advanced materials and semi-solid magnesium alloy injection molding.

US Stock Market Move | It was revealed that NVIDIA Corporation (NVDA.US) is developing a leading global open-source model, with its stock rising nearly 3% during the day.
A-shares Evening Highlights | Central Bank Makes Major Announcement! Related to Monetary Policy, Exchange Rates, etc.

TIAN CHANG GP (02182) has signed a construction agreement with Guangdong Zhongfu for the establishment of a new production facility for advanced materials and semi-solid magnesium alloy injection molding.

US Stock Market Move | It was revealed that NVIDIA Corporation (NVDA.US) is developing a leading global open-source model, with its stock rising nearly 3% during the day.

RECOMMEND





